Management

MANAGEMENT
Organisation
Organisation

Chemtrix BV is located on 2 sites. In Hull (United Kingdom) Dr Paul Watts CTO) and Dr Charlotte Wiles are running their Chemtrix R&D laboratory within facilities of The University of Hull. All the other activities (Management, Engineering, Product Development, Quality Assurance, Marketing & Sales) are located at the headquarters based on the Chemelot (www.chemelot.com) site in Geleen.


Chief Executive Officer: Ing Hugo Delissen
Chief Executive Officer: Ing Hugo Delissen

Chemical technology engineer, career at Philips in chemical & ceramic operations, product development and general management, started LWB International BV (2004), Nano Specials BV (2005), Kriya Materials BV (www.kriya-materials.com) (2006) and Chemtrix BV (2008)


Chief Technology Officer: Dr Charlotte Wiles
Chief Technology Officer: Dr Charlotte Wiles

Dr. Charlotte Wiles has been actively researching within the area of micro reactor technology for ten years, starting with a PhD entitled `Micro reactors in organic chemistry`, which she obtained from The University of Hull in 2003. In the past decade she has authored many scientific papers and review articles, recently co-authoring a book on the subject 'Micro reaction technology in organic synthesis'. More recently, she has tailored her experience to the development and evaluation of commercially available continuous flow reactors, systems and peripheral equipment.


Chief Scientific Advisor: Dr. Paul Watts
Chief Scientific Advisor: Dr. Paul Watts

Dr. Paul Watts graduated from the University of Bristol in 1995 with a first class B.Sc. in chemistry. He continued his studies at Bristol, obtaining a Ph.D. in bio-organic natural product chemistry in 1999. His Ph.D. focussed on the synthesis of isotopically labelled compounds, for use in determination of biosynthetic pathways to polyketide-derived natural products. Paul subsequently worked as a postdoctoral research associate at the University of Hull, where he pioneered organic synthesis in micro reactors.

In 2005, Watts initiated a joint venture with Lionix BV (Netherlands) to commercialise the technology, which has resulted in the formation of Chemtrix BV. Watts has a part time secondment to work with the company in the role of Chief Scientific Advisor.